Details for New Drug Application (NDA): 210602
✉ Email this page to a colleague
The generic ingredient in IBUPROFEN is ibuprofen sodium. There are sixty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ibuprofen sodium profile page.
Summary for 210602
Tradename: | IBUPROFEN |
Applicant: | Aptapharma Inc |
Ingredient: | ibuprofen |
Patents: | 0 |
Pharmacology for NDA: 210602
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 210602
Suppliers and Packaging for NDA: 210602
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
IBUPROFEN | ibuprofen | SUSPENSION;ORAL | 210602 | ANDA | PAI Holdings, LLC dba PAI Pharma | 0121-1022 | 0121-1022-00 | 10 CUP, UNIT-DOSE in 1 CASE (0121-1022-00) / 5 mL in 1 CUP, UNIT-DOSE |
IBUPROFEN | ibuprofen | SUSPENSION;ORAL | 210602 | ANDA | PAI Holdings, LLC dba PAI Pharma | 0121-1022 | 0121-1022-05 | 10 CUP, UNIT-DOSE in 1 TRAY (0121-1022-05) / 5 mL in 1 CUP, UNIT-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SUSPENSION;ORAL | Strength | 100MG/5ML | ||||
Approval Date: | Nov 23, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription